Definitive Hypofractionated Intensity-modulated Radiation Theraphy With Concurrent Chemotherapy in Cervical Cancer

Clinical trial NCT07439497 · RECRUITING

Trial details

NCT number: NCT07439497
Sponsor: Samsung Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer

Start date: 2025-12-09
Primary completion: 2026-05-30
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.